DistantNews
Support us
Kano Drug Availability Triples to Over 90% in Three Years
๐Ÿ‡ณ๐Ÿ‡ฌ Nigeria /Health & Science

Kano Drug Availability Triples to Over 90% in Three Years

From Vanguard · () English

Translated from English, summarized and contextualized by DistantNews.

At a glance

News Named sources New plan
  • Drug availability in Kano's public health facilities has surged from 30% to over 90% in three years, according to the Kano Drugs and Medical Consumables Supply Agency (DMCSA).
  • The agency's Director-General, Gali Sule, announced the achievement during the third anniversary of Governor Abba Yusuf's administration.
  • DMCSA also cleared N1.2 billion in inherited debts to pharmaceutical suppliers, restoring confidence and strengthening the medical supply chain.

Drug availability in Kano's public health facilities has dramatically increased to over 90 percent, a significant leap from the 30 percent recorded three years ago. Gali Sule, the Director-General of the Kano Drugs and Medical Consumables Supply Agency (DMCSA), announced this milestone during a press conference marking the third anniversary of Governor Abba Yusuf's administration.

Sule stated that the agency, responsible for procuring and distributing quality, affordable drugs and medical consumables, has made substantial progress. He noted that upon the current administration's assumption of office in 2023, essential medicines were largely unavailable, with availability standing at approximately 30 percent. Sustained government interventions, however, have since boosted the availability of medicines and medical commodities across the state.

"This achievement has been recognized and applauded across the country because we never imagined it could be attained within three years," Sule remarked, highlighting the widespread positive reception of the agency's performance. The DMCSA's success has not only improved healthcare access but also restored confidence in the state's medical supply chain.

Furthermore, the agency successfully cleared approximately N1.2 billion in debts owed to pharmaceutical suppliers, a liability inherited from previous administrations. This debt clearance, completed by January 2026, is described as a major milestone that rebuilt trust with suppliers. Governor Yusuf's commitment to settling these inherited debts has earned him an Award of Excellence and Appreciation from the Association of Nigerian Industrial Pharmacists, scheduled for presentation on July 16.

This achievement has been recognized and applauded across the country because we never imagined it could be attained within three years

โ€” Gali SuleDirector-General of DMCSA, commenting on the increase in drug availability.
DistantNews Editorial

Originally published by Vanguard in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.